Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy, Safety and Tolerability of Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Falciparum Malaria in Pregnancy: an Open-label, Randomised Controlled, Non-inferiority Trial

NCT01231113 is registered in ClinicalTrials.gov with Kwame Nkrumah University of Science and Technology as lead sponsor.

NCT NCT01231113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01231113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy, Safety and Tolerability of Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Falciparum Malaria in Pregnancy: an Open-label, Randomised Controlled, Non-inferiority Trial
Lead sponsor
Kwame Nkrumah University of Science and Technology
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2011
Completion date
February 28, 2013
Enrollment
417 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pregnancy complicated by malaria as antepartum condition